Crossmark

Enhanced Transdermal Delivery of Piroxicam via Nanocarriers, Formulation, Optimization, Characterization, Animal Studies and Randomized Double-Blind Clinical Trial

Crossref DOI link: https://doi.org/10.1208/s12249-025-03075-x

Published Online: 2025-03-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Masjedi, Moein https://orcid.org/0000-0003-3351-8730
Helforoush, Mohammad Ali

Rad, Katayoun Rohani

Mohammadi-Samani, Soliman

Montahaei, Talieh

Helforoush, Zarindokht

Amini, Afshin
License Information

Text and Data Mining valid from 2025-03-06

Version of Record valid from 2025-03-06
More Information

Article History

Received: 5 December 2024

Accepted: 18 February 2025

First Online: 6 March 2025

Declarations

:

: The authors have no conflict of interest to declare.

Document is current

Any future updates will be listed below